NIH-funded research R21 grant

Understanding how glioblastoma interacts with brain environments through tiny vesicles

Official title: GLIOMA INTERACTION WITH THE NEUROGENIC NICHE THROUGH EXTRACELLULAR VESICLES

Funded at Mayo Clinic Jacksonville · NIH-10999368 · Data updated 2026-11-12

This study is looking at how an aggressive brain tumor called glioblastoma interacts with its surroundings and how tiny particles released by cells might affect the tumor's growth, with the hope of finding new ways to improve treatment for patients like you.

Quick facts

Grant typeR21 grant
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville
NIH-funded
Lab location1 site (Jacksonville, United States)
Project startSeptember 1, 2024
Project endAugust 31, 2026
Funding year2024
Award (this year)$430,375
NIH project number1R21NS128212-01A1
Project IDNIH-10999368 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults diagnosed with glioblastoma, particularly those with tumors near the lateral ventricles.

Less likely to help

Patients with other types of brain tumors or those who are not diagnosed with glioblastoma may not receive benefit from this research.

What this research studies

This research investigates the aggressive brain tumor glioblastoma (GBM) and its interaction with the neurogenic niche, particularly focusing on how extracellular vesicles influence tumor behavior. By examining the relationship between GBM and the surrounding brain structures, the study aims to uncover mechanisms that contribute to tumor growth and recurrence. Patients may benefit from insights that could lead to new therapeutic strategies targeting these interactions, potentially improving treatment outcomes.

Why it matters

Potential benefit: If successful, this research could lead to innovative treatments that reduce glioblastoma recurrence and improve patient survival rates.

How similar studies have gone: Previous research has shown promising results in understanding tumor interactions with the neurogenic niche, indicating potential for breakthroughs in treatment.

Where this research is happening

  • Mayo Clinic Jacksonville
    Jacksonville, United States
    Active

Researchers

  • Principal investigator: Guerrero-Cazares, Hugo — Mayo Clinic Jacksonville
  • Study coordinator: Guerrero-Cazares, Hugo

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.